Physician profile
Philip M Manger
NPI 1699709089
$1,825.73
in general payments reported to CMS, 2019-2025
9 companies · $38.84 in 2025
The $38.84 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2020: $327 · 2021: $254 · 2022: $84.80 · 2023: $56.65 · 2024: $130 · 2025: $38.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $871.15 | 2019-2023 | Trudi Nav Cable |
| Medical Device Business Services, INC. | $414.45 | 2019 | |
| Aerin Medical INC. | $175.48 | 2020-2025 | |
| Preceptis Medical, INC. | $138.13 | 2020-2021 | |
| Intersect Ent, INC. | $121.60 | 2019 | |
| Stryker Corporation | $50.85 | 2020-2022 | |
| Integra Lifesciences Corporation | $22.39 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Smith+Nephew, INC. | $20.28 | 2020 | |
| Genentech USA, INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Manger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.